Latest

medicine

·July 26, 2012·5 min read

Study Pinpoints a Genetic Cause of Most Lethal Brain Tumor and May Lead to New Treatment

Researchers discovered that some cases of glioblastoma, the most common and aggressive form of primary brain cancer, are caused by the fusion of two adjacent genes. The study also found that drugs that target the protein produced by this genetic aberration can dramatically slow the growth of glioblastomas in mice.

Featured Neurology Neuroscience

·July 25, 2012·4 min read

Chemical Makes Blind Mice See

A team of University of California, Berkeley, scientists in collaboration with researchers at the University of Munich and University of Washington, in Seattle, has discovered a chemical that temporarily restores some vision to blind mice, and is working on an improved compound that may someday allow people with degenerative blindness to see again.

Brain Cancer Featured Neurology

·July 24, 2012·3 min read

New Probe Provides Vital Assist in Brain Cancer Surgery

A new probe developed uses an innovative fluorescence-reading technology to help brain surgeons distinguish cancerous tissue from normal tissue. The probe tool, now already in use at the Cancer Center for brain surgery, may one day be used for surgeries for a variety of cancers.

Featured Neurology

·July 24, 2012·4 min read

New Research Determines How a Single Brain Trauma May Lead to Alzheimer’s Disease

A study, performed in mice and utilizing post-mortem samples of brains from patients with Alzheimer’s disease, found that a single event of a moderate-to-severe traumatic brain injury (TBI) can disrupt proteins that regulate an enzyme associated with Alzheimer’s. The paper, published in The Journal of Neuroscience, identifies the complex mechanisms that result in a rapid and robust post-injury elevation of the enzyme, BACE1, in the brain. These results may lead to the development of a drug treatment that targets this mechanism to slow the progression of Alzheimer’s disease.

Featured Neurology Neuroscience

·July 23, 2012·3 min read

Synthetic Stimulants Called Bath Salts Act in the Brain Like Cocaine

Results of a new study offer compelling evidence for the first time that mephedrone, like cocaine, does have potential for abuse and addiction. “The effects of mephedrone on the brain’s reward circuits are comparable to similar doses of cocaine,” Dr. Malanga, a professor of neurology, pediatrics and psychology at UNC School of Medicine said. “As expected our research shows that mephedrone likely has significant abuse liability.”

Neurology Neuroscience Business

·July 19, 2012·2 min read

Anti-Tau Drug Improves Cognition, Decreases Tau Tangles in Alzheimer’s Disease Models

Penn Medicine research presented today at the 2012 Alzheimer's Association International Conference shows that an anti-tau treatment called epithilone D (EpoD) was effective in preventing and intervening the progress of Alzheimer's disease in animal models, improving neuron function and cognition, as well as decreasing tau pathology.

Electrophysiology Featured Genetics Neurology

·July 18, 2012·2 min read

Protein Build-Up Leads to Neurons Misfiring

Using a two-photon microscope capable of peering deep within living tissue, researchers at the University of California, San Diego School of Medicine have found new evidence that alpha-synuclein protein build-up inside neurons causes them to not only become leaky, but also to misfire due to calcium fluxes.

Featured Genetics Neurology Neuroscience Business

·July 17, 2012·3 min read

Experimental Drug May Extend Therapeutic Window for Stroke

An experimental drug that reduces brain damage and improves motor skills among stroke-afflicted rodents when given with federally approved clot-busting therapy has been created.

Featured Neuroscience Neuroscience Videos

·July 17, 2012·4 min read

Musical Glove Improves Sensation, Mobility for People with Spinal Cord Injury

Georgia Tech researchers have created a wireless, musical glove that may improve sensation and motor skills for people with paralyzing spinal cord injury (SCI).

Featured Neuroethics Neurology

·July 17, 2012·2 min read

Poisoning from Industrial Compounds Can Cause Similar Effects to ALS

Researchers from the Bellvitge Biomedical Research Institute at the University of Barcelona have coordinated research into how the IDPN nitrile causes neurological syndromes similar to those of the amyotrophic lateral sclerosis (ALS), a severe neuromuscular degenerative disease.

Autism Featured Psychology

·July 17, 2012·4 min read

Researchers Find Evidence of Link between Immune Irregularities and Autism

A new Caltech study suggests that specific changes in an overactive immune system can indeed contribute to autism-like behaviors in mice, and that in some cases, this activation can be related to what a developing fetus experiences in the womb.

Featured Genetics Neurology

·July 16, 2012·2 min read

Gene Therapy Treatment Extends Lives of Mice with Fatal Disease, Spinal Muscular Atrophy

Mice born with Spinal Muscular Atrophy typically only live five to six days. University of Missouri researchers introduced the SMN gene into the mice’s central nervous systems and were able to extend their lives 10-25 days longer.

1 … 59 60 61 62 63 … 69